Published online before print July 8, 2004, doi: 10.1161/01.RES.0000138449.85324.c5
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 1, 2004
Revised on June 24, 2004
Accepted on June 28, 2004
Creation of a Genetic Calcium Channel Blocker by Targeted Gem Gene Transfer in the Heart
Mitsushige Murata ;
From the Institute of Molecular Cardiobiology and Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, Md.
* To whom correspondence should be addressed. E-mail: marban{at}jhmi.edu.
Calcium channel blockers are among the most commonly used therapeutic drugs. Nevertheless, the utility of calcium channel blockers for heart disease is limited because of the potent vasodilatory effect that causes hypotension, and other side effects attributable to blockade of noncardiac channels. Therefore, focal calcium channel blockade by gene transfer is highly desirable. With a view to creating a focally applicable genetic calcium channel blocker, we overexpressed the ras-related small G-protein Gem in the heart by somatic gene transfer. Adenovirus-mediated delivery of Gem markedly decreased L-type calcium current density in ventricular myocytes, resulting in the abbreviation of action potential duration. Furthermore, transduction of Gem resulted in a significant shortening of the electrocardiographic QTc interval and reduction of left ventricular systolic function. Focal delivery of Gem to the atrioventricular (AV) node significantly slowed AV nodal conduction (prolongation of PR and AH intervals), which was effective in the reduction of heart rate during atrial fibrillation. Thus, these results indicate that gene transfer of Gem functions as a genetic calcium channel blocker, the local application of which can effectively modulate cardiac electrical and contractile function.
Key words: calcium channel blocker • gene therapy
This article has been cited by other articles:
 |
|
 |
|
  N. Beetz, L. Hein, J. Meszaros, R. Gilsbach, F. Barreto, M. Meissner, U. C. Hoppe, A. Schwartz, S. Herzig, and J. Matthes Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice Cardiovasc Res, December 1, 2009; 84(3): 396 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Levy, O. Beharier, Y. Etzion, M. Mor, L. Buzaglo, L. Shaltiel, L. A. Gheber, J. Kahn, A. J. Muslin, A. Katz, et al. Molecular Basis for Zinc Transporter 1 Action as an Endogenous Inhibitor of L-type Calcium Channels J. Biol. Chem., November 20, 2009; 284(47): 32434 - 32443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu and H. M. Colecraft Engineering Proteins for Custom Inhibition of CaV Channels Physiology, August 1, 2009; 24(4): 210 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Leyris, C. Gondeau, A. Charnet, C. Delattre, M. Rousset, T. Cens, and P. Charnet RGK GTPase-dependent CaV2.1 Ca2+ channel inhibition is independent of CaV{beta}-subunit-induced current potentiation FASEB J, August 1, 2009; 23(8): 2627 - 2638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Savelieva and J. Camm Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches Europace, June 1, 2008; 10(6): 647 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cingolani, G. A. Ramirez Correa, E. Kizana, M. Murata, H. C. Cho, and E. Marban Gene Therapy to Inhibit the Calcium Channel {beta} Subunit: Physiological Consequences and Pathophysiological Effects in Models of Cardiac Hypertrophy Circ. Res., July 20, 2007; 101(2): 166 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yada, M. Murata, K. Shimoda, S. Yuasa, H. Kawaguchi, M. Ieda, T. Adachi, M. Murata, S. Ogawa, and K. Fukuda Dominant Negative Suppression of Rad Leads to QT Prolongation and Causes Ventricular Arrhythmias via Modulation of L-type Ca2+ Channels in the Heart Circ. Res., July 6, 2007; 101(1): 69 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Beguin, Y. J. A. Ng, C. Krause, R. N. Mahalakshmi, M. Y. Ng, and W. Hunziker RGK Small GTP-binding Proteins Interact with the Nucleotide Kinase Domain of Ca2+-channel beta-Subunits via an Uncommon Effector Binding Domain J. Biol. Chem., April 13, 2007; 282(15): 11509 - 11520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Seu and G. S. Pitt Dose-dependent and Isoform-specific Modulation of Ca2+ Channels by RGK GTPases J. Gen. Physiol., November 1, 2006; 128(5): 605 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Crump, R. N. Correll, E. A. Schroder, W. C. Lester, B. S. Finlin, D. A. Andres, and J. Satin L-type calcium channel {alpha}-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1959 - H1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Finlin, R. N. Correll, C. Pang, S. M. Crump, J. Satin, and D. A. Andres Analysis of the Complex between Ca2+ Channel beta-Subunit and the Rem GTPase J. Biol. Chem., August 18, 2006; 281(33): 23557 - 23566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Finlin, A. L. Mosley, S. M. Crump, R. N. Correll, S. Ozcan, J. Satin, and D. A. Andres Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by the Rem2 GTPase J. Biol. Chem., December 23, 2005; 280(51): 41864 - 41871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chen, H. L. Puhl III, S.-L. Niu, D. C. Mitchell, and S. R. Ikeda Expression of Rem2, an RGK Family Small GTPase, Reduces N-Type Calcium Current without Affecting Channel Surface Density J. Neurosci., October 19, 2005; 25(42): 9762 - 9772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sasaki, T. Shibasaki, P. Beguin, K. Nagashima, M. Miyazaki, and S. Seino Direct Inhibition of the Interaction between {alpha}-Interaction Domain and {beta}-Interaction Domain of Voltage-dependent Ca2+ Channels by Gem J. Biol. Chem., March 11, 2005; 280(10): 9308 - 9312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Balijepalli, J. D. Foell, and T. J. Kamp Blocking the L-type Ca2+ Channel With a Gem: A Paradigm for a More Specific Ca2+ Channel Blocker Circ. Res., August 20, 2004; 95(4): 337 - 339. [Full Text] [PDF]
|
|